Drug addiction can be expressed as the condition which affects behaviour and brain of the individuals. When a person in addicted to drugs, he/she feels impulse to use the drug even if knowing harm related to use of drugs. The addiction is not only experienced in case of cocaine, heroin or illegal drugs but also in case of nicotine, opioid painkillers, alcohol and other legal substances can cause addiction. The continuos abuse of these drugs results in changing ability of brain which causes uncontrollable urge for consumption of drugs. The change in function of brain is occurs after the continuos consumption of drugs over a period of time. Which may result in losing in the self-control and damaging behaviour of the individuals.
The Europe drug addiction treatment market is witnessing rapid growth during the forecast period 2021-2027. The rising number of smokers and drinkers is gaining the attention of Europe drug addiction treatment market. The dynamic factors like legislation of marijuana in certain states for medical use in propelling the market growth. Technological development results in advanced diagnostic laboratories is also refuelling the market growth. Rise in government initiatives and increasing awareness programs about drug addiction is also elevating the market growth of Europe drug addiction treatment market. Conversely, reluctance among addicts to available treatment is hampering the market growth. Lack of treatment compliance is also hindering the market growth.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the drug addiction treatment market. In addition, complete analysis of changes on drug addiction treatment expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The drug addiction increases the risk of COVID-19. The tobacco/nicotine, marijuana, heroin or cocaine have shown unhealthier lung conditions like chronic obstructive pulmonary diseases, asthma and chronic lung diseases may rises risk of severe illness from COVID-19. The use of stimulants such as methamphetamine, cocaine rises risk of stroke, heart attack, abnormal heart rhythm, seizures along with other conditions that may lead to more severe lung damage to the patient affected by COVID-19 as because of that drug addiction treatment market is witnessing positive impact on the drug addiction treatment market.
The Europe drug addiction treatment market is segmented by drug type, treatment, end user and country.
The Europe drug addiction treatment market is comprised of drug types like tobacco/ nicotine and vaping, alcohol, marijuana, synthetic cannabinoids and over the counter medications. In which marijuana is also contributing in the market growth of Europe drug addiction treatment market. Marijuana use can cause development of problems which is also called as marijuana use disorders, which is converted into addiction in severe cases. The person experienced the withdrawal symptoms when the drug is not consumed. The frequent user of marijuana may experience irritability, mood and sleep difficulties, decreased appetite, cravings, restlessness and different types of physical discomfort under the first week after quitting and may last up to two weeks.
The Europe drug addiction treatment market is comprised of treatments like detoxification, counselling and behavioural therapies, rehabilitation program, self-help groups and medications. In which rehabilitation is also contributing in the market growth. The rehabilitation is the action of restoring of someone’s health or normalised life by various training and therapy after the addictions. In simple word rehabilitation is process of returning to healthy or good way of life or helping individual in normalising its life after the addiction, imprisonment and very illness. The rehabilitation is done by drug treatment, educating families of patients and providing psychological support through outpatient care.
The end users like hospitals, homecare, speciality clinics and other are comprised in the Europe drug addiction treatment market. In which homecare facilities is also contributing in the market growth. The homecare facilities provides all the essential care to the patient at home. Which includes medicines, food and psychological care to the addicts at their home. It also plays important role in screening their juvenile patients and providing brief interventions and also provides ongoing monitoring and follow up of the addicted persons.
The Europe drug addiction treatment market is studied for countries like UK, Germany, France, Spain and Italy. In which UK is anticipated to dominate the market in 2020. The rising government initiatives for restricting the drug abuse is propelling the market growth. The increasing collaboration of manufacturer and new product launch strategies is also boosting the market growth. The rising deaths due to drug addiction is also refuelling the market growth of the Europe drug addiction treatment market.
The major key players like Hager Biosciences Llc, Addex Therapeutics, Omeros Corporation, Sosei Group Corporation, Cv Sciences Inc, Cerecor Inc, Astraea Therapeutics Llc, Johnson & Johnson Services Inc., Glaxosmithkline Plc, Pfizer Inc, Novartis Ag, Sanofi, Dr. Reddy’S Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Mylan N.V., Axsome Therapeutics Inc, H. Lundbeck A/S, Zydus Cadila and Glenmark Pharmaceuticals Ltd among other are analysed in the market.
November 2018: The Sandoz collaborated with pear therapeutic and announced introduction of reSET® for treatment of patients with substance use disorder. It is novel and only discovered drug approved by FDA-authorized prescription digital therapeutic treatment of drug addiction conditions.
October 2017: The Maryland addiction recovery centre of towson and carcon treatment centres announced their new collaboration along the enterprises and takeover of encore recovery solutions which is located in Arlington, Virginia.
June 2017: Pfizer collaborated with Eli Lily and co. for development of non-opioid chronic pain medication called tanezumab. The collaboration got the fast-track approval by Food and Drug administration for treatment of chronic back pain and osteoarthritis.
The study comprised of drug addiction treatment market. In which study analysed the various segments of the market. The drug addiction treatment market is bifurcated by drug type, treatment and end users. The study also comprised of dominating segment of the market. The drug type segment is dominated by alcohol. Likewise, treatment segment is dominated by self-help groups and end user is dominated by hospitals. The study also imparts the geographical section of the market and it concludes that United Kingdom is anticipated to dominate the market in 2020. The study comprised of impact of COVID-19 on drug addiction treatment market and it is profounds that drug addiction increases the risk of COVID-19. The tobacco/nicotine, marijuana, heroin or cocaine have shown unhealthier lung conditions like chronic obstructive pulmonary diseases, asthma and chronic lung diseases may rises risk of severe illness from COVID-19. The use of stimulants such as methamphetamine, cocaine rises risk of stroke, heart attack, abnormal heart rhythm, seizures along with other conditions that may lead to more severe lung damage to the patient affected by COVID-19 as because of that drug addiction treatment market is witnessing positive impact on the drug addiction treatment market. The study also imparts major key players operating in the market.
Why to buy this report